Psilocybin and psilocin are two terms frequently tossed around in the psychedelic community, but do many truly understand their distinct roles? Masha Ty. brings clarity by discussing their differences and how they influence user experience. As per the transcript, "Psilocybin is not necessarily the active compound; it's the pro drug that gets metabolized into psilocin, the active hallucinogenic form."

Masha emphasizes how bioavailability plays a crucial role, noting that "psilocin helps bind to serotonin receptors, making it more bioavailable." This difference could explain why some individuals experience fewer gastrointestinal issues when consuming psilocin compared to psilocybin.

Lemon Tek, a popular preparation method within the psychedelic community, may provide an edge here. As explained by Masha, "When you Lemon Tek, it brings out the psilocin, which can result in less nausea and vomiting." Given that every user metabolizes substances differently, this insight might pave the way for more reliable and comfortable psychedelic experiences.

In today's episode of Psychedelic Healing, host Sonia invites Masha Ty to traverse the intersection of corporate acumen and the burgeoning psychedelic space. With Masha's extensive background in corporate America and her subsequent shift towards the cannabis and psychedelics realm, listeners will be enthralled by her unique insights into the transformative potential of these substances. As the head of corporate growth at ACS Laboratory, Masha's role in navigating the transition of industries from the black market to a legal, regulated environment takes center stage.

Diving deeper, the episode reveals the nuances behind testing psychedelics and discusses the evolution of the industry, highlighting Masha's commitment to patient education and demystifying the scientific aspects of psychedelics. Listeners will get an inside look at the lab testing process, the compounds present in mushrooms, and Masha's perspectives on the lesser-known Amanita Muscaria mushrooms, as well as key factors to consider when evaluating psychedelic products on the market.

The discourse of integrating psychedelics into leadership and entrepreneurship is blazing new trails. As we traverse this illuminating path, key insights from thought leaders like Jackson Strong, CEO of AUREA, offer innovative perspectives on how the ancient wisdom of psychedelics is harmonizing with the burgeoning era of purpose-driven leadership. Through his journey from a successful tech entrepreneur to a spiritual guide for modern-day changemakers, Strong illuminates the potential of psychedelics to catalyze deeper connections with life and elevate our collective consciousness.

The episodes starts with an exploration into what Jackson Strong refers to as "the new golden age". Strong describes this not merely as a phrase but as an alignment of numerous cosmic and prophetic cycles — a crescendo of time and philosophy where catastrophic global events coincide with a massive resurgence in spirituality and self-discovery, often facilitated by psychedelics. Strong's metamorphosis from a tech entrepreneur to a catalyst in spiritual entrepreneurship and leadership is deeply telling of how one’s personal growth journey can have a broader communal impact. He describes this evolution with candor, detailing his own ventures and psychedelic experiences that led him to realize his true callings beyond the corporate sphere.

The intriguing realm of psychedelic therapy opens doors to potential healing and consciousness expansion beyond traditional medical approaches. In a candid conversation, Shannon Stark, a board-certified psychiatric nurse practitioner and a trailblazer in ketamine psychotherapy, reveals how combining this psychedelic with integrative practices ushers in a new era of mental health treatment.

Ketamine stands out in its potential as a therapeutic agent, especially when coupled with integration and intentionality. According to Stark, "the results and the experiences and the possibilities consistently seen with my clients is quite extraordinary", emphasizing ketamine's role in facilitating deep shifts in mental health conditions. This episode offers an insightful exploration into how ketamine, when administered in a controlled and supportive setting, becomes a powerful lever for neuroplasticity and insight.

Psychedelics have emerged as a frontier of hope in mental health, offering transformative experiences for those grappling with traumas that defy traditional therapies. As we delve into the heartrending journey of Alex Abraham, a survivor of childhood sexual abuse, we encounter a narrative that challenges our understanding of healing and confronts the potential of psychedelics in catalyzing profound personal change.

The journey of healing with psychedelics often begins with the introspection and revelation of memories long buried within the psyche. For Alex, MDMA-assisted psychotherapy was the key that unlocked his childhood experiences of sexual abuse. This radical encounter with his past was not without its challenges. As Abraham's experience highlights, the somatic effects of trauma often manifest as physical ailments — an area where psychedelics have shown promising results.

The entwined paths of modern psychiatry and the reemergence of psychedelics have led to revolutionary approaches to mental health care. Through the shared journey of psychedelic research and therapy, we are rediscovering ancient wisdom and combining it with contemporary science to unlock the potential for healing that lies within our own minds. From combating long-term mental illness to mitigating everyday stress, psychedelics, alongside innovative technologies, are offering new avenues for lasting wellness.

In this episode of Psychedelic Healing we speak with Dr. Dave Rabin, a psychiatrist and neuroscientist. We discuss the transformative power of psychedelic-assisted psychotherapy and the importance of creating a safe and healing environment for patients. Dr. Rabin also introduces Apollo Neuroscience, a wearable technology that uses touch therapy to induce a state of calm and relaxation. We explore the integration of Apollo with psychedelic treatments, highlighting the potential for enhanced experiences and improved outcomes.

In a revealing and profound discussion, Daniel Carcillo, a former professional athlete turned mental health advocate, speaks with us about his odyssey through the trials of post-concussion syndrome and traumatic brain injury to find redemption in psychedelic medicine. As a two-time Stanley Cup winner with the Chicago Blackhawks, Carcillo's endorsement of psychedelics offers a unique peek into the future of mental health treatment and its intersection with personal resilience and revolutionary medical therapies.

Psychedelic medicine is proving to be a substantial ally in the fight against mental health challenges, especially those related to traumatic brain injuries (TBI) and post-concussion syndrome. As Carcillo narrates, his salvation came in the form of psilocybin, a substance traditional pharmaceuticals failed to parallel in effectiveness. His recovery is not just an anecdote but a testament that calls for a broader acceptance and understanding of psychedelic therapy.

The exploration of psychedelics in mental health is a burgeoning field, daring to reshape the landscape of traditional therapy. At the forefront of this paradigm shift are clinicians pioneering an integrative approach to addiction and chronic pain management. Through a fusion of pharmacology with holistic measures trailblazers, such as Dr. Howard Kornfeld and Inna Zelikman of Recovery Without Walls, are unlocking transformative healing possibilities within psychedelic-assisted therapies.

In Part two of our conversation we lead further into the nuance of dosing - a cornerstone for the efficacy of ketamine-assisted therapy. Kornfeld and Zelikman describe their methodical process, a precise titration starting from 0.5 milligrams per kilogram and adjusting according to individual responses. "We can, you know, set the right dose for a patient to have that psychedelic experience," Ina Zelikman explains, shedding light on the careful personalization that dictates the journey's course. This emphasis on individualization underscores the critical role of the patient-clinician dynamic and the imperative of adapting each treatment to unique physiological and psychological landscapes.

The resurgence of research and clinical interest in psychedelics like psilocybin, MDMA, and ketamine is offering new pathways for treating various health conditions. While ketamine has been adopted in psychotherapy, there's an increasing need to understand and manage its addiction potential as reported by patients in therapeutic settings. Today we delve into the transformative healing power of psychedelics with guests Dr. Howard Kornfeld and nurse practitioner Inna Zelikman on this part one of two episode. 

Dr. Kornfeld, a trailblazer in addiction medicine and pain management, shares his journey from studying psychedelics in the 60s to becoming a prominent figure in the field. Inna, the director of integrative mental health at Recovery without Walls, with a background in holistic nursing. By retracing the roots and examining the blossoming of psychedelic therapy, Kornfeld and Zelikman enlighten us on the vast potential these substances hold for healing. Meanwhile, as recovery without walls exhibits, blending historical context, scientific advancement, and personal empathy will likely be the guiding components for the future of psychedelic healing.

Po-Hong Yu is a seasoned medicine woman, acupuncturist, spiritual guide, and somatic energy healer with a profound dedication to guiding individuals back to their inherent bodily wisdom. By facilitating the healing of unprocessed pain, she enables her clients to blossom into their authentic selves. Po is adept at utilizing microdosing protocols to enact significant changes in the brain and nervous system, leading to a more vibrant, flourishing existence. She is also the host of her own podcast, "Dao of Po," which delves into personal healing journeys and the wider magical experiences of life.

 This discussion captures the essence of somatic healing, unveiling the critical connection between our physical symptoms and internal emotional states. Po expertly demystifies the concept while delineating her approach to guiding individuals through microdosing protocols. She advocates for small yet potent daily gestures—like setting one's intention before microdosing—to catalyze deep-seated transformation. Ensuing conversations pivot to her innovative "Anger Alchemy" program, offering listeners a keen understanding of recognizing and processing repressed anger for profound healing.